The future of research is both patient-centric and AI-empowered, and TrialX is building a better way to manage it. Through our unified platform, we simplify recruitment workflows, expand access, and power innovative trials on Earth and in space. At SCOPE Europe 2026, Eric shared how leading pharmaceutical companies use our enterprise-grade global platform to streamline patient recruitment, unify study workflows, and help participants find the clinical trials right for them. He also highlighted best practices for scaling site-sponsor connectivity and how agentic AI and intelligent automation are shaping personalized patient engagement strategies. Thank you to everyone who connected with us at Booth #7 in Barcelona. We enjoyed exchanging ideas with leaders across the clinical research community on the future of patient recruitment and clinical trial innovation. 🚀
🕵 What We’re Hearing From The Field
“At DPHARM 2026 in Boston last month, we met with sponsors and CROs to discuss the ongoing challenges of patient recruitment workflows. A recurring theme was the friction of managing fragmented systems and the need for clear end-to-end visibility from initial outreach through enrollment. We demonstrated how TrialX unifies this entire journey, combining AI-powered trial finders, study websites, referral tracking, site workflows, and real-time analytics in one platform. A major highlight was co-presenting with Pfizer, as Danielle Foster (Clinical Trial Ecosystem Infrastructure Lead, Pfizer) and Wes Martz (Senior Director, Client Services, TrialX) shared how bringing recruitment technology in-house gives sponsors greater control, simplifies operations, and creates a seamless experience for patients and sites. We look forward to building on this momentum at SCOPE Europe!”
Beth Dickson, VP, Business Development
What’s New at TrialX! 🚀
🎥 RECENT WEBINAR
Clinical trial recruitment websites often rely on prescreening to help potential participants determine whether a study may be a good fit. If you’re part of a pharma company, academic medical center, or patient advocacy organization looking to make prescreening more effective and scalable, we invite you to watch this webinar where we share how thoughtful prompt design can create effective AI-generated prescreeners that turn complex eligibility criteria into clear, patient-friendly questions. You’ll also learn how to prioritize meaningful screening criteria, create clear answer choices, and balance effective prescreening with the risk of turning away potentially eligible participants.
❇️ SUCCESS STORIES
We are thrilled to announce that a top 10 global pharmaceutical company has chosen TrialX as its end-to-end patient recruitment and engagement platform. By unifying trial discovery, pre-screening, site referrals, sponsor workflows, and real-time analytics into a fully connected ecosystem, the objective is to streamline site operations and accelerate patient access to life-saving research across the entire clinical trial lifecycle. Learn more.
Our enterprise recruitment platform helped a top-five pharmaceutical sponsor standardize recruitment processes and deploy enterprise-level analytics across its clinical portfolio. This provided clear cross-portfolio visibility, enabling the team to pinpoint operational inefficiencies at scale. After uncovering a critical drop-off between site referral and study enrollment, the sponsor implemented an enhanced prescreening process—significantly improving participant readiness and boosting overall enrollment rates. Download case study.
We built a patient-centric global clinical trial website enabling potential participants to discover the sponsor’s recruiting studies across 18+ countries. Leveraging AI-powered tools and integrations, the platform translates and simplifies trial information into plain language and guides visitors to the next step toward trial participation through integrated prescreening and referral to study sites. Download case study.
❇️ PRODUCT HIGHLIGHTS
CADASIL (Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy) is a rare genetic condition affecting small blood vessels in the brain, often leading to vascular cognitive impairment and dementia. We are proud to empower researchers at the University of Wisconsin with a custom mobile research app designed to capture critical insights into how CADASIL progresses, paving the way for better care and future interventions. Learn More.
Space missions demand health monitoring in environments with limited connectivity and extreme conditions where traditional tools often fall short. TrialX Space Health Systems is an offline-capable, AI-powered platform that collects and analyzes diverse datasets, from wearables to genomics, even beyond Earth’s grid. Remote health research is possible, wherever the mission goes. Learn More.
📺 MEDIA & PRESS
Our Co-founder & CEO, Sharib Khan, was featured in Clinical Research News in the article “Space Health Research Could Rack Up Many Earthly Dividends.” The piece highlights how our space health research innovations – developed in collaboration with the Translational Research Institute for Space Health (TRISH), are enabling the collection of vital human health data from commercial spaceflights, with implications that extend beyond astronauts to advance clinical research on Earth. Read the full story.
🎓 SPOTLIGHT
UNSUNG BUT IMPACTFUL VOICES OF CLINICAL RESEARCH HEROES
“What does the patient need?” For José Ajenjo of Sanofi, that question has shaped his work across clinical operations, patient recruitment, innovation, and diversity initiatives. In our latest spotlight, José shares how his personal experience with healthcare access has shaped his commitment to making clinical research more accessible, equitable, and patient-centered. 🔗 Read the interview.
RECENT CURETALKS 
In this CureTalks session, Dr. Angela DeMichele and Dr. Lewis A. Chodosh of the University of Pennsylvania discuss the challenges breast cancer survivors face and the lingering risk of recurrence. Drawing on findings from their CLEVER trial published in Nature Medicine, they explore how targeting dormant tumor cells could help eliminate them before they develop into aggressive metastatic tumors. Watch here.
🧬FEATURED CLINICAL STUDIES
Powered by TrialX
COPD Treatment Study: Researchers are testing a treatment for people with COPD to see whether blocking proteins linked to lung inflammation can improve breathing and symptoms. Participants receive the study treatment or placebo alongside standard COPD care for 24 weeks.
BLAAC PD: Global Parkinson’s Genetics Program implemented by The Michael J. Fox Foundation for Parkinson’s Research, is studying health, disease, and genetic factors linked to Parkinson’s disease in Black and African American communities. People with and without Parkinson’s can participate, helping researchers build a more diverse understanding of the disease and advance future treatments.
ADDS-UP3 Eczema Study: Penn Medicine researchers are studying how environmental factors affect eczema in adults. Participants complete surveys, wear a small air-quality monitor, and provide a home dust sample over one year to help researchers better understand factors that may influence skin health.
Brain and Hunger Study: Indiana University researchers are studying how the brain responds to hunger and fullness in people with different body types. Participants undergo MRI scans while viewing food images and wear a continuous glucose monitor to help researchers understand appetite and weight regulation.
🌎AROUND THE WEB
🫁 Anti-aging bonus: A lung drug may also slow biological aging.
🌕 Lunar mystery: Moon dust could hold clues to ancient alien technology.
🤖 AI research leap: AI agents can talk to each other and uncover scientific discoveries.
🧬 CRISPR cholesterol: A one-time treatment cut “bad” cholesterol in half for a year.
🩺 AI urgent care: Google’s medical chatbot shows promise in a clinical trial.
‼️NOTEWORTHY
At TrialX, we strive to revolutionize the way clinical trials are conducted on earth and in space, by focusing on AI powered solutions to simplify global patient recruitment management and remote data collection. Stay tuned for more updates as we continue to look up to the Moon & Mars!
All the best,
Team TrialX
